Efficacy News and Research

RSS
CSC, ALS TDI extend collaboration in advancing potential stem cell therapy for ALS

CSC, ALS TDI extend collaboration in advancing potential stem cell therapy for ALS

Celsis IVT alleges patent infringement, files lawsuit against Sekisui Chemical and subsidiaries

Celsis IVT alleges patent infringement, files lawsuit against Sekisui Chemical and subsidiaries

Hovione announces filing of new drug application in Japan for the influenza drug CS-8958

Hovione announces filing of new drug application in Japan for the influenza drug CS-8958

Javelin Pharmaceuticals' NDA for Dyloject Injection accepted for formal review

Javelin Pharmaceuticals' NDA for Dyloject Injection accepted for formal review

Medco Health Solutions acquires DNA Direct

Medco Health Solutions acquires DNA Direct

Overview of newly evolving technologies for diagnosing and monitoring HIV infections

Overview of newly evolving technologies for diagnosing and monitoring HIV infections

Decision Resources: Benlysta to garner more than $500M in 2018

Decision Resources: Benlysta to garner more than $500M in 2018

Pervasis Therapeutics reaches agreement with FDA on pivotal Phase 3 clinical trial for Vascugel

Pervasis Therapeutics reaches agreement with FDA on pivotal Phase 3 clinical trial for Vascugel

YM BioSciences-Cytopia merger complete

YM BioSciences-Cytopia merger complete

Ipsen reports consolidated group sales of €1,032.8M for 2009

Ipsen reports consolidated group sales of €1,032.8M for 2009

WHO pneumonia expert honored with PACE Global Leadership Award

WHO pneumonia expert honored with PACE Global Leadership Award

FDA approved 53 new oncology and hematology drugs between 2005 and 2007

FDA approved 53 new oncology and hematology drugs between 2005 and 2007

Congressman Rothman secures 1.49M in federal dollars for EHMC's bloodless medicine program

Congressman Rothman secures 1.49M in federal dollars for EHMC's bloodless medicine program

New vaccine effective in preventing TB in HIV patients

New vaccine effective in preventing TB in HIV patients

ConjuChem Biotechnologies reports financial results for fiscal year ended October 31, 2009

ConjuChem Biotechnologies reports financial results for fiscal year ended October 31, 2009

ChromoCure retains Patent & Intellectual Property Attorneys to assess its Intellectual Property portfolio

ChromoCure retains Patent & Intellectual Property Attorneys to assess its Intellectual Property portfolio

Johns Hopkins University School of Nursing: Research news

Johns Hopkins University School of Nursing: Research news

Global market for oncology drugs is forecast to reach $80 billion by 2050

Global market for oncology drugs is forecast to reach $80 billion by 2050

Thoratec reports revenues of $373.9M for fiscal 2009

Thoratec reports revenues of $373.9M for fiscal 2009

Experimental vaccine protects mice and monkeys against chikungunya virus

Experimental vaccine protects mice and monkeys against chikungunya virus

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.